Investigating Photoactive Antimicrobials as Alternatives (or Adjuncts) to Traditional Therapy

RJH Hammond,, ML De Avellar. Antibiotic Resistance Protocols, 51-56

Monitoring Live Mycobacteria in Real-Time Using a Microfluidic Acoustic-Raman Platform

M Chen, V Baron, B Hammarström, RJH Hammond,, P Glynne-Jones, SH Gillespie, K. Dholakia. Antibiotic Resistance Protocols, 109-119

Investigating Combination Therapy as a Means to Enhance Activity and Repurpose Antimicrobials

RJH Hammond. Antibiotic Resistance Protocols, 43-49

Using Hollow Fiber to Model Treatment of Antimicrobial-Resistant Organisms

RJH Hammond. Antibiotic Resistance Protocols, 57-64

Rapid Drug Susceptibility Testing to Preserve Antibiotics

SH Gillespie, RJH Hammond,. Antibiotic Resistance Protocols, 129-143

The appropriateness of empirical antibiotic therapy in the management of symptomatic urinary tract infection patients-a cross-sectional study in Nairobi County, Kenya

H Onyango, DJ Sloan, K Keenan, M Kesby, C Ngugi, H Gitonga, RJH Hammond.  Journal of Antimicrobial Chemotherapy; Antimicrobial Resistance Aug 2024 6(4).

Rapid determination of antimicrobial susceptibility of Gram-negative bacteria from clinical blood cultures using a scattered light-integrated collection device 

K Falconer,  RJH Hammond, BJ Parcell, SH Gillespie. Journal of Medical Microbiology

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers 

A Liu, RJH Hammond, PD Donnelly, JC Kaski, ARM Coates. Journal of Internal Medicine 

Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19 

A Liu, RJH Hammond, K Chan, C Chukwuenweniwe, R Johnson, D Khair... PLoS One 18(4) 

Low CRB-65 scores effectively rule out adverse clinical outcomes in COVID-19 irrespective of chest radiographic abnormalities 

A Liu, RJH Hammond, K Chan, C Chukwuenweniwe, R Johnson, D Khair... Biomedicines 11(9) 

Comparison of Lymphocyte–CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19 

A Liu, RJH Hammond, K Chan, C Chukwuenweniwe, R Johnson, D Khair... Journal of Personalized Medicine 13(6)

Characterisation of ferritin–lymphocyte ratio in COVID-19 

A Liu, RJH Hammond, K Chan, C Chukwuenweniwe, R Johnson, D Khair... Biomedicines 11(10) 

222 nm Far‐UVC from filtered K rypton‐C hloride excimer lamps does not cause eye irritation when deployed in a simulated office environment 

O Kousha, P O'Mahoney, RJH Hammond, K Wood, E Eadie. Photochemistry and Photobiology 

A simple label-free method reveals bacterial growth dynamics and antibiotic action in real-time

RJH Hammond, K Falconer, T Powell, R Bowness, SH Gillespie. Scientific Reports 12 (1), 19393

Skin safety and efficacy of filtered far ultraviolet C for SARS-CoV-2 inactivation 

E Eadie, RP Hickerson, MJ Conneely, RJH Hammond, SKH Tsutsumi... British Journal of Dermatology 

Improving the recovery and detection of bloodstream pathogens from blood culture

K Falconer, RJH Hammond, SH Gillespie. Journal of Medical Microbiology 69 (6), 806

Real-time monitoring of live mycobacteria with a microfluidic acoustic-Raman platform

VO Baron, M Chen, B Hammarstrom, RJH Hammond, P Glynne-Jones, … Communications biology 3 (1), 1-8

Rapid Determination of Antimicrobial Susceptibility of Gram-Negative Bacteria from Positive Blood Cultures Using an Innovative Method

Kerry Falconer, Ben Parcell, Robert Hammond, Stephen Gillespie. Access Microbiology 2 (2), 37

Data underpinning: Real-time monitoring of live mycobacteria with a microfluidic acoustic-raman platform

Vincent Olivier Baron, Mingzhou Chen, Bjorn Hammarstrom, Robert James Hunter Hammond, Peter Glynne-Jones, Stephen Henry Gillespie, Kishan Dholakia. University of St Andrews

Can phenotypic data complement our understanding of antimycobacterial effects for drug combinations?

Frank Kloprogge, Robert Hammond, Andrew Copas, Stephen Henry Gillespie, Oscar Della Pasqua. Journal of Antimicrobial Chemotherapy 74 (12), 3530-3536

Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection

Frank Kloprogge, Robert Hammond, Karin Kipper, Stephen H Gillespie, Oscar Della Pasqua. Scientific reports 9 (1), 1-8

A SLIC answer to a continuing problem

R Hammond.  Access Microbiology 1 (1A), 655

Centrifugation and decontamination procedures selectively impair recovery of important populations in Mycobacterium smegmatis

JA Kennedy, VO Baron, RJH Hammond, DJ Sloan, SH Gillespie.  Tuberculosis 112, 79-82

Enhanced methodologies for detecting phenotypic resistance in Mycobacteria

RJH Hammond, VO Baron, S Lipworth, SH Gillespie.  Antibiotic Resistance Protocols

Label-free optical vibrational spectroscopy to detect the metabolic state of M. tuberculosis cells at the site of disease

VO Baron, M Chen, SO Clark, A Williams, RJH Hammond, Kishan Dholakia, …Scientific reports 7 (1), 1-9

Defining dormancy in mycobacterial disease

S Lipworth, RJH Hammond, VO Baron, Y Hu, A Coates, SH Gillespie.  Tuberculosis 99, 131-142

Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?

RJH Hammond, VO Baron, K Oravcova, S Lipworth, SH Gillespie.  Journal of Antimicrobial Chemotherapy 70 (10), 2823-2827

A Simple Label-Free Method Reveals Bacterial Growth Dynamics and Antibiotic Action in Real-Time

RJH Hammond, K Falconer, T Powell, SH Gillespie.  Available at SSRN 3887447

Centrifugation and decontamination procedures selectively impair recovery of important populations in Mycobacterium smegmatis

RJH Hammond, K Falconer, T Powell, SH Gillespie.  Available at SSRN 3887447